InvestorsHub Logo
Followers 24
Posts 2651
Boards Moderated 0
Alias Born 04/03/2005

Re: None

Monday, 12/25/2017 6:26:01 AM

Monday, December 25, 2017 6:26:01 AM

Post# of 203916
..here's the 'eyes of the World' as I see it ~ protecting my IP from all the soon-to-be knuckle heads and crooks once the onslaught relentless buying if CBD and THC combo cues cures.

~ Fabulous Christmas present from WHO

AND IT IS ABOUT FREEKING TIME!!!

Cannabidiol (CBD)
"There is increased interest from Member States in the use of cannabis for medical indications including for palliative care. Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.

To that end, the ECDD did an initial review of a cannabis compound called cannabidiol (CBD). Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions. Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance). The ECDD therefore concluded that current information does not justify scheduling of cannabidiol and postponed a fuller review of cannabidiol preparations to May 2018, when the committee will undertake a comprehensive review of cannabis and cannabis related substances."

$OWCP

The very first words are "how do you do" - the last..